semaglutide 2.0 mg approval The UK's MRHA has approved a injection (Wegovy) to treat metabolic-associated steatohepatitis (MASH) - Novo Nordisk Semaglutide: Uses, Dosage, Side Effects,

Clinical trial participants who achieved the most significant outcomes consistently combined pharmacological treatment with dietary modification and increased physical activity

Wegovy (semaglutide), which was approved in 2021 (it was previously available for diabetes as Ozempic and in an oral form for diabetes as Rybelsus)

A NOVEL study has shown that Glucagon-like peptide-1 (GLP-1) agonists, medications widely used for obesity and type 2 diabetes, may offer benefits for patients with hidradenitis suppurativa (HS), a chronic inflammatory skin condition often associated with obesity

In January 2024, the state opted to pull back that coverage

Faggiano, A

It is marketed by Novo Nordisk as an injection as the drug Ozempic and as an oral tablet as Rybelsus